Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
814.00    -5.00 (-0.61%)
Bid:
816.00
Ask:
817.00
Spread: 1.00 (0.123%)
Market Cap: £767.09m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

11 Jan 2018 07:00

RNS Number : 5307B
Polar Capital Holdings PLC
11 January 2018
Β 

11 January 2018 Polar Capital Holdings plc

AUM Update

Β 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM") and performance fees earned for the calendar year to 31 December 2017.

Β 

Group AUMΒ (unaudited)

Β 

Polar Capital reports that as at 31 December 2017 its AUM were Β£11.7bn compared to Β£9.3bn at the end of March 2017. AUM increased by Β£1.1bn in the quarter of which Β£597m were net inflows and Β£507m related to market movement and performance.

Β 

AUM movement in nine months to 31 December 2017

Long only

funds

Alternative funds

Total

AUM at

31 March 2017

Β£8,447m

Β£826m

Β£9,273m

Net subscriptions

Β£1,145m

Β£272m

Β£1,417m

Market movement

and performance

Β£952m

Β£65m

Β£1,017m

Total AUM at

31 December 2017

Β£10,544m

Β£1,163m

Β£11,707m

Β 

Comment

Β 

The Group has had a satisfactory quarter with pleasing net inflows despite the termination of four underperforming funds during the quarter.

Β 

This update confirms that the momentum of net inflows over the past quarters has continued and the final performance fee profits for the year that crystallised at the end of December are a significant improvement on last year's figure.

Β 

It is encouraging to report that the Group's investment teams are well placed in terms of performance and fund flows to continue their growth into 2018. The Group has a firm footing from which to implement its strategy of diversifying investment strategies, client domicile and client segments.

Β 

Net performance fees (unaudited)

Β 

The table below sets out the position relating to net performance fee profits (after the deduction of staff interests) earned in the first nine months of the Group's financial year.

Β 

Performance fee profit

net of staff allocations

Nine months to

31 Dec 16

Year to

31 Mar 17

(year-end)

Nine months to

31 Dec 17*

Net performance fee profit

Β£1.2m

Β£1.2m

Β£15.0m*

Β 

\* The figures to December 2017 are enhanced by Β£2.4m due to the IFRS requirement for the cost of deferred staff allocations to be spread over the period of deferment. The amount of net deferral will be reflected in the Adjusted Earnings Per Share figure that will be reported at the financial year-end.

Β 

For further information please contact:

Β 

Polar Capital

Gavin Rochussen (Chief Executive)John Mansell (COO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

Andrew Buchanan

Margarita Mitropoulou

+44 (0)20 7523 8000

Β 

Peel Hunt - Joint Broker

Guy Wiehahn

+44 (0)20 7418 8893

Camarco

Ed Gascoigne-Pees

Β 

+44 (0)20 3757 4984

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCEAKFEFDAPEFF
Date   Source Headline
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018
11th Jun 201811:27 amRNSNet Asset Value(s)
1st Jun 20187:41 amRNSTotal Voting Rights
24th May 201810:59 amRNSDirector/PDMR Shareholding
24th May 20189:35 amRNSIssue of Equity
23rd May 201811:00 amRNSNotice of Results
23rd May 20189:37 amRNSIssue of Equity
18th May 20181:02 pmRNSIssue of Equity
16th May 20185:49 pmRNSIssue of Equity
11th May 20187:00 amRNSIssue of Equity
10th May 20189:56 amRNSDirector/PDMR Shareholding
1st May 20183:52 pmRNSIssue of Equity
12th Apr 20187:00 amRNSAuM Update
5th Apr 20187:00 amRNSIssue of Equity
20th Mar 20182:19 pmRNSIssue of Equity
5th Feb 20183:15 pmRNSBlock listing Interim Review
18th Jan 20183:02 pmRNSHolding(s) in Company
18th Jan 20182:59 pmRNSHolding(s) in Company
18th Jan 20182:57 pmRNSDirector/PDMR Shareholding
17th Jan 20185:45 pmRNSIssue of Equity
11th Jan 20184:55 pmRNSIssue of Equity
11th Jan 20187:00 amRNSAUM Update
11th Dec 20177:00 amRNSUnaudited Interim Results
20th Nov 201710:43 amRNSNotice of Interim Results
15th Nov 201710:36 amRNSForm 8.3 - Gocompare.com Group Plc
8th Nov 201710:32 amRNSForm 8.3 - Aldermore Group Plc
7th Nov 201711:34 amRNSForm 8.3 - Aldermore Group Plc
1st Nov 20179:24 amRNSHolding(s) in Company
1st Nov 20177:00 amRNSTotal Voting Rights
31st Oct 201710:33 amRNSForm 8.3 - Aldermore Group Plc
30th Oct 201711:26 amRNSForm 8.3 - Aldermore Group Plc
27th Oct 201710:18 amRNSForm 8.3 - Aldermore Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.